4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001493152-23-036404
CEO, CFO, Director gave up 397 shares (to pay taxes)
- CEO, CFO, Director acquired 1,309 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Finley John David CEO, CFO, Director | 2023-10-03 | Option exercise | +1,309 | 44,703 | D | ||
| Finley John David CEO, CFO, Director | 2023-10-04 | Shares withheld for taxes | −397 | $0.55 | $218 | 44,306 | D |
| Derivatives | |||||||
| Finley John David CEO, CFO, Director | 2023-10-03 | Option exercise · Restricted Stock Units | −1,309 | 1,309 | D | ||
Loading xslF345X05/ownership.xml…